Last reviewed · How we verify
NCT05816512: GNPG
Antimicrobial Efficacy of Biogenic Gold Nano Particle From Pelargonium Graveolens Leaves Extract Mouthwash for Children
NA trial testing Gold Nano particle from Pelargonium Graveolens Mouthwash in Dental Caries in 60 participants. Status unknown.
20 September 2023
Quick facts
| Lead sponsor | Ahmed Yousif Mahdi |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 April 2023 |
| Primary completion | 20 September 2023 |
| Estimated completion | 20 March 2024 |
| Sites | 1 location across Iraq |
Drugs / interventions tested
- Gold Nano particle from Pelargonium Graveolens Mouthwash — full drug profile →
- Chlorhexidine gluconate mouthwash . — full drug profile →
Conditions studied
- Dental Caries — all drugs for Dental Caries →
- Gingivitis — all drugs for Gingivitis →
- Periodontitis — all drugs for Periodontitis →
Sponsor
Ahmed Yousif Mahdi — full company profile →
Who can join
Adults 7 to 14, male only, with Dental Caries or Gingivitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study is randomized controlled trial ... The null hypothesis of the present study is that there is no antibacterial efficacy of gold nanoparticles of pelargonium graveolens mouthwash against Streptococcus mutans and Candida Albicans . Meanwhile the alternative hypothesis of the present study is that gold nanoparticles of pelargonium graveolens mouthwash have antimicrobial activity against Streptococcus mutans and Candida Albicans .
Publications & conference data
5 peer-reviewed publications reference this trial (live from Europe PMC):
-
Gold nanostructures in melanoma: Advances in treatment, diagnosis, and theranostic applications.
Dastgheib ZS, Abolmaali SS, Farahavar G, Salmanpour M, et al · · 2024 · cited 14× · PMID 39170173 · DOI 10.1016/j.heliyon.2024.e35655 -
Harnessing Nature's Toolbox: Naturally Derived Bioactive Compounds in Nanotechnology Enhanced Formulations.
Sanjai C, Gaonkar SL, Hakkimane SS. · · 2024 · cited 10× · PMID 39494011 · DOI 10.1021/acsomega.4c07756 -
Medical importance and pharmacokinetics of gold nanoparticles in the human body.
Singh P, Joshi AS, Singh H, Mijakovic I. · · 2025 · cited 8× · PMID 41068777 · DOI 10.1186/s12943-025-02418-3 -
Phytonanotherapy for the Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease.
Nendouvhada LP, Sibuyi NRS, Fadaka AO, Meyer S, et al · · 2024 · cited 5× · PMID 38891759 · DOI 10.3390/ijms25115571 -
Antimicrobial Efficacy of Pelargonium Graveolens Gold Nanoparticles: A Novel Mouthwash for Children.
Asker AYM, Al Haidar AHMJ. · · 2026 · PMID 42036760 · DOI 10.1111/idh.70071
Verify or expand the search:
- PubMed search for NCT05816512
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Dental Caries
Currently open trials in the same condition.
- NCT06787261 — Involvement of Archaea in Carious Disease · NA · recruiting
- NCT06753669 — Mothers' Action Project for Child Health · NA · recruiting
- NCT07431463 — Effects of Different Remineralization Agents on the Progression of Non-Cavitated Approximal Carious Lesions in Primary T · NA · active not recruiting
- NCT07134114 — Occlusal Impact of Hall Crowns in Primary Molars · NA · recruiting
- NCT07181967 — SDF vs Fluoride Varnish for Streptococcus Mutans Reduction in Children · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05816512 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ahmed Yousif Mahdi
- Last refreshed: 18 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05816512.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing